/ Print /

HOSPITAL & PROVIDER STRATEGY

How Healthcare Spin-Offs are Affecting the IndustryJohn R. Washlick, Buchanan, Ingersoll & Rooney, and expert in healthcare system transactions and market consolidation, talks to Managed Healthcare Executive about healthcare spin-offs, what that means for the future of mergers and acquisitions, and advice for healthcare executives.
Top 10 Cities for Healthcare Jobs in 2018A new report reveals the top cities that rise to the top for healthcare—and they’re probably not the cities you’d expect.
Six Ways to Support Healthcare Staff During DownsizingThe healthcare landscape is transforming. Here are six considerations to help your talent during restructuring, downsizing, and other transitions.
Five Things that Change the Quality Measurement and Reporting GameMake the rules work for, rather than, against you by relying on these five critical capabilities.
Three Ways Healthcare Organizations Can Improve Care ManagementHere are three strategies to navigate toward next-generation care management and increase member engagement in the process
Three Barriers to Biosimilar AdoptionUnderstanding the key barriers to biosimilar adoption in the U.S. is the first step managed care executives can take to overcome these obstacles, according to a Trinity Parners report.
How telemedicine will change care delivery and costs in 2018Health systems realize that telehealth can help them achieve a wide range of objectives, from care coordination to readmission avoidance and market share expansion.
Some Consumers Set to Receive Complimentary Cancer Genomic ProfilingShift represents growing understanding of value of genetic testing for cancers. Find out who is receiving the test and why.
Amazon, JPMorgan, Berkshire Hathaway collaboration puts insurers ‘on notice’Corporate giants Amazon, Berkshire Hathaway, and JPMorgan Chase, partner to shake things up in U.S. employee healthcare.
Seven Ways to Help Patients Access Costly Cancer DrugsTwo new studies reveal that cost-restraints can keep patients from accessing life-preserving cancer drugs.